An Empirical Study on the Impact of drug licensing on sales

DOI

10.2991/icemaess-18.2018.65How to use a DOI?

Keywords

drug licensing, sales, T-test, Q-test

Abstract

To study the impact of drug licensing on its sales, and to provide a reference for drug development and corporation between pharma. METHODS: Based on the variables “license station”, “co-development or co-marketing”, “licensor in accord with key marketing company or not” and “time for drug licensing” which reflected drug licensing and sales, with SPSS statistical software, T-test and Q-test of drug licensing and the sales of drugs were carried out on the 151 sample drugs collected in IMS Health. RESULTS & CONCLUSIONS: Drugs with licensing activities have higher sales than those without licensing. There is no significant difference between co-development and co-marketing for the drugs, Licensor hold the key marketing right helps improve sales of drugs. The optimum time for drug licensing is phase Ⅲ.

Copyright

© 2018, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Qi-hang Wang
AU  - Chen Cao
AU  - Yuan-jia HU
PY  - 2018/11
DA  - 2018/11
TI  - An Empirical Study on the Impact of drug licensing on sales
BT  - Proceedings of the 2018 5th International Conference on Education, Management, Arts, Economics and Social Science (ICEMAESS 2018)
PB  - Atlantis Press
SP  - 312
EP  - 317
SN  - 2352-5398
UR  - https://doi.org/10.2991/icemaess-18.2018.65
DO  - 10.2991/icemaess-18.2018.65
ID  - Wang2018/11
ER  -